Dietary Intake of Alpha-linolenic Acid in Elderly

NCT03025620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 254

Last updated 2017-01-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the antiatherogenic and anti-inflammatory potential of an adequate intake of alpha-linolenic acid in elderly.

Conditions

Interventions

DIETARY_SUPPLEMENT

Rapeseed oil

Active comparator arm : Dietary Supplement: rapeseed oil supplementation (10g per day) and margarine with a high level of alpha-linolenic acid (12.5g per day) during 42 days.

DIETARY_SUPPLEMENT

Sunflower oil

Placebo comparator arm : Dietary Supplement: sunflower oil supplementation (10g per day) and margarine with a high level of inoleic acid (12.5g per day) during 42 days.

Sponsors & Collaborators

  • Institut Elevage

    collaborator UNKNOWN
  • ITERG

    collaborator INDUSTRY
  • SAINT HUBERT

    collaborator UNKNOWN
  • TERRES UNIVIA

    collaborator UNKNOWN
  • TERRES INOVIA

    collaborator UNKNOWN
  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • olivier henry, MD · Assistance Publique de Paris. Hopital Emile Roux

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2011-02-28
Completion
2011-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025620 on ClinicalTrials.gov